One of the biggest challenges to developing an efficient metabolic inhibitor targeting Gln catabolism is delineating the metabolic fate of Gln in vivo
#Pharmacy #PharmD #GLP1 #ObesityMedicine #MedicationSafety #PatientCare #WeightManagement To view or add a comment, sign in CLINICAL PEARL OF THE DAY Why should Proton Pump Inhibitors (PPls) be taken 30-60 minutes before meals
Clinical studies indicate that alterations in the microbiome precede and forecast treatment responses, implying the possibility for individualized therapeutic strategies based on initial microbiotic profiles (Perraudeau et al
Severe Vitamin B12 Deficiency Presenting as Pancytopenia, Hemolytic Anemia, and Paresthesia: Could Your B12 Be Any Lower
The first line of defense against sulfide toxicity is often sulfide:quinone oxidoreductase (SQR), an enzyme that catalyzes the oxidation of H 2 S to sulfane sulfur (S 0 ), bound to a low-molecular-weight (LMW) thiol such as glutathione (GSH) to form a LMW thiol persulfide, e.g
10.1371/journal.ppat.1000952 PLoS Pathog